Managing Director, Afrigen Biologics
Petro Terblanche has extensive experience developing and managing research portfolios for clinical research projects for single and in combination therapy in the field of medical oncology and in planning, executing and publishing original research aimed at decision support and policy development in the field of environmental health. She has been the lead negotiator on several license agreements in the field of food, fine chemical and pharmaceuticals and has been instrumental in the creation of start-up companies for profit and non –profit purposes. She has played a key role in the development and implementation of South Africa’s Biotechnology strategy since 1999. She is, currently, the Managing Director at Afrigen Biologics, a start-up Biotech company, and Part time full Professor at North-West University. Prior to these roles, Petro Terblanche has been Managing Director of Pelchem SOC Ltd., a high technology fluorochemical production, sales and distribution Company, she held the position of Group Executive Research and Development at South African Nuclear Energy Corporation, and she served as Executive Director of the Food, Biological and Chemical Technologies Division at South Africa’s Council of Scientific and Industrial Research. Moreover, she has been the President of the Stakeholder Association of the Global Alliance for YB Drug Discovery and Development, based in New York. Currently, Petro Terblanche serves also in many Committees and Boards, such as Chairperson Bone SA NPC Board of Directors, Board of Directors Afrigen Biologics Pty Ltd, Industrial Advisory Group Molecular Sciences Institute at Wits School of Chemistry, Advisory Committee for the University of Pretoria’s Center for Sustainable Malaria Control and the Institute of Molecular and Cellular Biology.